UBS Group’s AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF NVBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-161
Closed -$4.53K 11292
2026
Q1
$4.53K Buy
161
+59
+58% +$1.71K ﹤0.01% 8926
2025
Q4
$2.95K Sell
102
-147
-59% -$4.22K ﹤0.01% 9178
2025
Q3
$7.05K Buy
+249
New +$6.81K ﹤0.01% 8749
2025
Q2
Sell
-34
Closed -$843 11057
2025
Q1
$843 Sell
34
-67
-66% -$1.72K ﹤0.01% 9642
2024
Q4
$2.58K Buy
+101
New +$2.62K ﹤0.01% 9022

Other funds holding NVBU

UBS Group's NVBU Position: Q2 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF (NVBU) in Q2 2026, closing a stake of 161 shares — an estimated $4.53K sold.

UBS Group first reported a position in NVBU in Q4 2024 and held it in 5 quarters. The position peaked at $7.05K in Q3 2025. 24 funds tracked by Wall St. Rank hold NVBU as of Q2 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 161 AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF shares in Q2 2026, an estimated $4.53K.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF in Q4 2024 and held it in 5 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF position peaked at $7.05K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.